Split Creek Capital’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.79M Hold
6,860
– – 1.69% 9
2026
Q2
$1.73M Hold
6,860
– – 1.59% 10
2026
Q1
$1.49M Buy
6,860
+500
+8% +$111K 1.57% 11
2025
Q4
$1.45M Buy
+6,360
New +$1.45M 1.54% 12

Other funds holding ABBV

Split Creek Capital's ABBV Position: Q3 2026 in Review

Split Creek Capital held its AbbVie (ABBV) position steady in Q3 2026 at 6,860 shares worth $1.79M. The position accounts for 1.69% of the portfolio, ranked #9.

Split Creek Capital first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Split Creek Capital held 6,860 shares of AbbVie worth $1.79M as of Q3 2026.
  • Split Creek Capital left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 1.69% of Split Creek Capital's portfolio in Q3 2026, its #9 holding.
  • Split Creek Capital first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Split Creek Capital's 13F filing for Q3 2026, filed 2 Nov 2026.